Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 18 are a HOLD (3.39%), 513 are a BUY (96.61%).
Analyst Andrew Fein, currently employed carries an average stock price target met ratio of 31.16% that have a potential upside of 50.81% achieved within 144 days. Previously, Andrew Fein worked at HC WAINWRIGHT.
Andrew Fein’s has documented 1,077 price targets and ratings displayed on 57 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 15-Nov-2024.
Analyst best performing recommendations are on SVRA (SAVARA).
The best stock recommendation documented was for SVRA (SAVARA) at 6/12/2019. The price target of $6 was fulfilled within 1 day with a profit of $4.57 (43.24%) receiving and performance score of 432.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$10.58 (64.43%)
$27
13 days ago
(07-Nov-2024)
8/22 (36.36%)
$9.79 (56.89%)
119
Buy
$28
$11.58 (70.52%)
$28
13 days ago
(07-Nov-2024)
0/4 (0%)
$10.79 (62.70%)
Hold
1 months 10 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$6.58 (40.07%)
$30
3 months 12 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$20
$3.58 (21.80%)
$28
3 months 13 days ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
Which stock is Andrew Fein is most bullish on?
Which stock is Andrew Fein is most reserved on?
What Year was the first public recommendation made by Andrew Fein?